CarThera   Report issue

For profit Phase 2
Founded: Paris France (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2019
NCT03744026
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CarThera

Active Ingredients

Drugs in Phase 2 Trials (1)

carboplatin (paraplatin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glioblastoma (Phase 2)

Gliosarcoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1